Unité Pharmaceutique des Essais Cliniques- Hôpital Lariboisière Fernand-Widal (UPEC)

What Unité Pharmaceutique des Essais Cliniques- Hôpital Lariboisière Fernand-Widal (UPEC) does

Hôpital Lariboisière - Fernand-Widal (UPEC) is a public university hospital located in the 10th arrondissement of Paris, operated by Assistance Publique-Hôpitaux de Paris (AP-HP) and affiliated with Université Paris Cité. The establishment operates across two sites — Lariboisière (2 rue Ambroise-Paré) and Fernand-Widal (200 rue du Faubourg Saint-Denis) — and functions as one of 7 hospitals within the GHU AP-HP Nord group. It provides comprehensive medical, surgical, and obstetric care including general and specialized emergency services, a Level 2A maternity unit with neonatology, and tertiary specialty departments spanning cardiology, neurology, neurosurgery, orthopedics, pain medicine, diabetology, infectious diseases, and geriatrics. The hospital also coordinates multiple national reference centers for rare diseases (vascular anomalies, bipolar disorders, complex bone and joint infections via CRIOAC) and a 24/7 regional Poison Control Center.

The hospital's core technology infrastructure includes the Siemens Naetom Alpha photon-counting CT scanner installed in February 2025, AI-assisted diagnostic tools in radiology and anatomical pathology, and 17 operating theaters. It hosts 5,200+ registered clinical trials and is a leading site for HIV PrEP research, having followed more than 4,000 PrEP patients. Operational volumes include 2,500+ coronarographies and 1,400+ angioplasties annually, 1,000+ heart failure patients, 250+ cardiac rehabilitation patients, 3,200+ pain medicine consultations, and 119,000 staff meals plus 461,000 patient meals served in 2024.

Revenue is generated through the French Sécurité Sociale under the T2A (activity-based tariff) reimbursement framework, supplemented by MIGAC mission-based grants and research funding from entities including ANRS/MIE, INSERM, and Fondation FondaMental. There are no private investors, no funding rounds, and no equity ownership — this is a state-owned public healthcare institution. The hospital is currently mid-transformation through the Nouveau Lariboisière modernization project, with the new facility expected to open in 2026 featuring 88% single rooms compared to the current 52%.

Name

Unité Pharmaceutique des Essais Cliniques- Hôpital Lariboisière Fernand-Widal (UPEC)

Legal name

Assistance Publique-Hôpitaux de Paris (AP-HP)

Website

https://hopital-lariboisiere.aphp.fr

Company type

Public

Operating status

Operating

Headcount range

11–50 employees

Short description

Hôpital Lariboisière - Fernand-Widal is a public university hospital in Paris's 10th arrondissement, operated by AP-HP, delivering emergency, surgical, maternity, and specialty care across two sites and coordinating national reference centers for rare diseases.

Ownership category

akta.pro rank

Product category

University Hospital Services

NAICS

General Medical and Surgical Hospitals (62211), General Medical and Surgical Hospitals (6221)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industry

Hospital-Based Emergency Departments (EDs) (HLAFADAA)

Keywords

• University hospital services
• Clinical research trials
• Emergency medical care
• Specialized medical centers
• Public healthcare services

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Public Healthcare Services: The hospital operates as part of the French public healthcare system (Sécurité Sociale). Revenue is generated through reimbursable medical procedures, consultations, hospitalizations, and examinations covered by the French national health insurance system. Additional funding comes from research grants and partnerships.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Public university hospital operating as part of AP-HP Nord and Université Paris Cité, providing comprehensive medical, surgical, maternity, and emergency care across multiple specialties (cardiology, neurology, oncology, geriatrics, infectious diseases, etc.). The hospital also operates a clinical trials registry with 5,200+ registered trials and runs national reference centers for rare diseases including vascular anomalies and bipolar disorders.

Product overview

Hôpital Lariboisière - Fernand-Widal is a major university hospital center (part of AP-HP Nord and Paris Cité University) offering comprehensive medical services across multiple specialties. The hospital provides emergency care (general and specialized), maternity services (Type 2A with neonatology), and specialized departments including cardiology, neurology, neurosurgery, orthopedics, pain management, geriatrics, infectious diseases, and diabetology. The institution operates a clinical trials registry with over 5,200 registered trials and maintains specialized centers for rare diseases including vascular anomalies and bipolar disorders. Key services include PrEP/HIV prevention programs, poison control, and advanced medical imaging with cutting-edge technology including the Naetom Alpha photon-counting CT scanner.

Differentiator

Problem solved

Functional benefit

Brands

• GHU AP-HP. Nord. Université Paris Cité: The hospital group (Groupement Hospitalo-Universitaire) that Hôpital Lariboisière - Fernand-Widal belongs to, alongside other north Paris hospitals.
• Nouveau Lariboisière

Products and services

• General and Specialized Emergency Services Comprehensive 24/7 emergency care including one general emergency department and two specialized emergency departments serving Paris's 10th arrondissement.
• Maternity Services (Type 2A with Neonatology) Level 2A maternity facility with neonatology unit providing care for premature newborns over 33 weeks, specializing in high-risk pregnancies and postpartum hemorrhage management.
• Cardiology Services Cardiology services including heart failure management, interventional cardiology with complex angioplasties, coronary complications in diabetics, antithrombotic treatment, and cardiac rehabilitation. The 2nd largest interventional cardiology center in Paris AP-HP, performing 2,500+ coronarographies and 1,400+ angioplasties annually.
• Clinical Trials Registry Comprehensive clinical trials registry with over 5,200 registered trials across multiple therapeutic areas including cardiology, neurology, infectious diseases, oncology, and rare diseases.
• PrEP (Pre-Exposure Prophylaxis) Services Comprehensive HIV pre-exposure prophylaxis program including consultations, multiple clinical trial protocols (PREVENIR, DOXY PK, ANRS SimpPrEP, LENACAPAVIR PrEP, ANRS CABOPrEP), and STI screening services. Over 4,000 patients followed.
• Diabetology and Endocrinology Department Specialized care for unstable type 1 diabetes (including islet transplants, insulin pumps, closed-loop systems, telemonitoring), monogenic and mitochondrial diabetes, pituitary and thyroid pathologies, and adrenal disorders.
• Pain Medicine and Palliative Care Reference center for complex chronic pain management with expertise in facial neuralgia (especially trigeminal neuralgia), migraines, chronic headaches, and neuropathic pain. Over 3,200 annual medical consultations.
• Poison Control Center Regional poison control center providing specialized advice on diagnosis, prognosis, treatment, and prevention of human poisonings, along with occupational pathology services, operating 24/7.
• Rare Vascular Anomalies Reference Center National reference center coordinator for superficial vascular anomalies in children and adults, providing multidisciplinary expertise in diagnosis and treatment of vascular tumors and malformations. Operating since 1976.
• Bipolar Disorder Expert Center Ambulatory center specializing in clinical, diagnostic, and therapeutic evaluation of patients with confirmed or suspected bipolar disorder, affiliated with Fondation FondaMental network.
• Medical Physics and Rehabilitation Rehabilitation services for disabilities related to nervous system and musculoskeletal deficits from vascular, traumatic, and infectious causes, specializing in stroke, traumatic brain injury, and polio.
• Geriatric Services Comprehensive geriatric care including acute geriatric medicine, mobile geriatric intervention teams, orthopedic surgery support, rehabilitation, and long-term care at Fernand-Widal site.
• Neurosurgery Services Complete cranial and spinal neurosurgery care for adults including brain, nerve, meninges, skull base, and spine pathologies. Team of 11 neurosurgeons led by Pr Sébastien Froelich.
• Radiology Services with Naetom Alpha Scanner Advanced medical imaging services including musculoskeletal, visceral, and vascular radiology. Equipped with state-of-the-art Naetom Alpha photon-counting CT scanner for enhanced diagnostic capabilities.

Quantifiable outcome

• 5200+ clinical trials registered, demonstrating extensive research output
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability6 records

Feature5 records

Partnerships

Ten partnerships are on record, tiered core, major and minor.

• FAVA-multi NetworkcoreStrategic or Co-development Partner · 1 January 2024National reference center network for superficial vascular anomalies (anomalies vasculaires superficielles) coordinated by Lariboisière hospital. The network comprises 2 reference centers and 12 competence centers distributed across France, with international collaborations through European Reference Networks (ERN).
• Fondation FondaMentalcoreStrategic or Co-development Partner · 1 January 2007Partnership with Fondation FondaMental (established 2007 under the Ministry of Higher Education and Research) to operate Centre Expert Bipolaire, a specialized center for bipolar disorder evaluation and treatment. The center provides multidisciplinary assessment, diagnostic confirmation, and therapeutic management as part of the national network of expert centers.
• Hôpital Necker-Enfants MaladescoreStrategic or Co-development PartnerCollaborative relationship for vascular anomalies care, with Necker handling pediatric cases and providing cross-referrals for complex adult cases requiring specialized interventions available at Lariboisière.
• European Reference Networks (ERN)majorStrategic or Co-development PartnerParticipation in European Reference Networks for rare diseases, enabling cross-border healthcare collaboration and knowledge sharing for vascular anomalies and other rare conditions.
• Patient Associations (VASCAPA, A.M.L.A, Neuro MAV France)minorGTM or Marketing PartnerCollaboration with patient organizations for vascular anomalies including VASCAPA (Vascular Anomaly Patient Association), A.M.L.A (Agir pour la Malformation Lymphatique en Alliance), and Neuro MAV France to support patient education, awareness, and community support.
• ANRS / MIE (Agence Nationale de Recherches sur le Sida et les Maladies Infectieuses)coreStrategic or Co-development PartnerCollaborative research partnership for HIV prevention and infectious disease studies. The hospital participates in multiple ANRS clinical trials including PREVENIR, DOXY PK, ANRS SimpPrEP, LENACAPAVIR PrEP, and ANRS CABOPrEP studies on PrEP optimization and new prevention strategies.
• AIDES AssociationminorGTM or Marketing PartnerMonthly presence of the AIDES association at the hospital to provide support for patients regarding psychoactive substance use and harm reduction, particularly for ChemSex practices among PrEP patients.
• SIHU / CRIOAC NetworkcoreStrategic or Co-development PartnerCentre de Référence des Infections Ostéo-Articulaires Complexes (CRIOAC) participates in the FHU PROTHEE2 hospital-university federation for complex bone and joint infections, collaborating with orthopedists, microbiologists, pharmacists, and paramedical teams.
• Université Paris CitécoreStrategic or Co-development PartnerUniversity hospital affiliation with Université Paris Cité enables academic research collaboration, medical education, and access to cutting-edge research programs and resources.
• INSERM Research UnitscoreStrategic or Co-development PartnerCollaborations with INSERM research units including U1148 (LVTS at Hôpital Bichat), UMR 1141 (NeuroDiderot at Lariboisière), and UMR S11 (ICAN at Pitié-Salpêtrière) for fundamental and clinical research on vascular anomalies and related conditions.

Scale indicators12 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Hôpital Necker-Enfants Malades: AP-HP pediatric university hospital and named partner of Lariboisiere for vascular anomaly care (adult/pediatric cross-referrals). Direct peer for rare-disease reference-center coordination and shared INSERM research platforms.
• Hospices Civils de Lyon (HCL): France's second-largest public university hospital group after AP-HP, with comparable scope in clinical research, multi-specialty referral care, and rare-disease reference centers. Direct structural peer for benchmarking scale, research output, and digital patient services.
• Hôpital Bichat-Claude Bernard: Sister hospital within GHU AP-HP Nord – Université Paris Cité, located in northern Paris. Same parent organization and shared GHU strategy, with comparable university-hospital services and the Plateforme Maladies Rares Paris Nord.
• Hôpital Saint-Antoine: AP-HP eastern-Paris university hospital with comparable multi-specialty footprint (cardiology, internal medicine, surgery) and a shared public-hospital reimbursement model. Direct peer in the Paris academic-hospital landscape.
• Hôpital Européen Georges Pompidou: Modern AP-HP university hospital in western Paris built around high single-room ratios and integrated digital care — a direct architectural and operational benchmark for Lariboisiere's Nouveau Lariboisiere project. Strong cardiology, oncology, and cardiovascular overlap.
• Hôpital Tenon: AP-HP university hospital in eastern Paris with overlapping multi-specialty services and shared Université Paris Cité affiliation. Functions as a comparable community-plus-specialty public academic hospital.
• Hôpital Saint-Louis: Co-member of GHU AP-HP Nord and bi-site infectious-diseases department partner with Lariboisiere. Comparable AP-HP university hospital with hematology/oncology depth, used as a reference for shared departmental governance and patient pathways.
• Hôpital Cochin: AP-HP central-Paris university hospital with overlapping multi-specialty services including cardiology, internal medicine, and obstetrics. Direct peer under shared AP-HP operating model and similar academic-affiliation profile via Université Paris Cité.
• CHU de Bordeaux – Hôpital Pellegrin: Major regional French university hospital complex with similar specialty-coverage ambitions and a bi-site Lariboisiere-style configuration. Direct peer for cross-regional comparison of inpatient volume, cardiology, and rare-disease services.
• Hôpital Pitié-Salpêtrière: AP-HP's largest university hospital in southern Paris, offering comparable multi-specialty inpatient care, advanced research, and rare-disease reference centers. Direct peer given overlapping specialty portfolios (cardiology, neurology, neurosurgery) and shared AP-HP funding/governance model with Lariboisiere.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/upec-lrb

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unité Pharmaceutique des Essais Cliniques- Hôpital Lariboisière Fernand-Widal (UPEC)